# Use of mOPV1 in Routine Immunization in Pakistan.

> **NCT04504539** · NA · UNKNOWN · sponsor: **Aga Khan University** · enrollment: 560 (estimated)

## Conditions studied

- Oral Polio Vaccine

## Interventions

- **BIOLOGICAL:** mOPV
- **BIOLOGICAL:** bOPV
- **BIOLOGICAL:** Full dose IPV
- **BIOLOGICAL:** fractional IPV

## Key facts

- **NCT ID:** NCT04504539
- **Lead sponsor:** Aga Khan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08
- **Primary completion:** 2021-05
- **Final completion:** 2021-12
- **Target enrollment:** 560 (ESTIMATED)
- **Last updated:** 2020-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04504539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04504539, "Use of mOPV1 in Routine Immunization in Pakistan.". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT04504539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*